Apalutamide decreased risk of death in mCSPC by 23% and 26% compared with enzalutamide and abiraterone acetate, respectively.

Those of us committed to finding cures for diseases must remain steadfast in our dedication, regardless of the level of ...

The secretary of Health and Human Services, Robert F. Kennedy Jr., contradicted his agency's researchers this week with unsubstantiated or outright false claims about autism spectrum disorder and ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...